World's Best Scientists 2026 revealed!
Jesús F. San Miguel

Jesús F. San Miguel

Award Badge
Medicine
Spain
2026

D-Index & Metrics

Medicine

D-Index
163
Citations
129019
World Ranking
673
National Ranking
5

Research.com Recognitions

  • 2026 - Research.com Medicine in Spain Leader Award
  • 2025 - Research.com Medicine in Spain Leader Award
  • 2023 - Research.com Medicine in Spain Leader Award

Overview

Jesús F. San Miguel is affiliated with the University of Navarra in Spain and has contributed extensively to research in medicine, with a particular focus on hematology, molecular biology, and oncology. Their work spans multiple specialized subfields including hematology, molecular biology, oncology, genetics, and radiology, nuclear medicine, and imaging.

The scientist's main topics of research include:

  • Multiple Myeloma Research and Treatments
  • Protein Degradation and Inhibitors
  • CAR-T cell therapy research
  • Peptidase Inhibition and Analysis
  • Monoclonal and Polyclonal Antibodies Research
  • Chronic Lymphocytic Leukemia Research
  • Cancer Treatment and Pharmacology

Jesús F. San Miguel has published several recent papers in prominent medical journals. Notable publications include:

  • Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma, 2023, New England Journal of Medicine
  • Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma, 2021, New England Journal of Medicine
  • Teclistamab in Relapsed or Refractory Multiple Myeloma, 2022, New England Journal of Medicine
  • The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee, 2022, Blood
  • Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, 2021, Annals of Oncology

The scientist collaborates frequently with other researchers in the field. Some of their frequent co-authors include María-Victoria Mateos, Bruno Paiva, Joaquin Martínez-López, Albert Oriol, and Paula Rodríguez-Otero.

Jesús F. San Miguel's research has been published predominantly in high-impact journals, with the most frequent publication venues being Blood, Journal of Clinical Oncology, Clinical Lymphoma Myeloma & Leukemia, HemaSphere, and Blood Cancer Journal.

They have also contributed to book publications, including one with Springer Nature (Netherlands) titled Advances in Italian Mechanism Science, published in 2020.

Best Publications

  • International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

    S. Vincent Rajkumar;Meletios A. Dimopoulos;Antonio Palumbo;Joan Blade

  • International staging system for multiple myeloma.

    Philip R. Greipp;Jesus San Miguel;Brian G.M. Durie;John J. Crowley

  • International uniform response criteria for multiple myeloma

    B. G. M. Durie;J.-L. Harousseau;J. S. Miguel;J. Blade

  • Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

    Paul G. Richardson;Pieter Sonneveld;Michael W. Schuster;David Irwin

  • Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

    Robert A. Kyle;J. Anthony Child;Kenneth Anderson;Bart Barlogie

  • International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

    Shaji Kumar;Bruno Paiva;Kenneth C. Anderson;Brian Durie

  • Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.

    Jesús F. San Miguel;Rudolf Schlag;Nuriet K. Khuageva;Meletios A. Dimopoulos

  • Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

    Antonio Palumbo;Hervé Avet-Loiseau;Stefania Oliva;Henk M. Lokhorst

  • Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma

    Meletios Dimopoulos;Andrew Spencer;Michael Attal;H. Miles Prince

  • Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

    Xose S. Puente;Magda Pinyol;Víctor Quesada;Laura Conde

  • Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

    Nikhil C Munshi;Larry D Anderson;Nina Shah;Deepu Madduri

  • Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma

    Meletios A. Dimopoulos;Albert Oriol;Hareth Nahi;Jesus San-Miguel

  • Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma

    Abstr Act;Sagar Lonial;Meletios Dimopoulos;Antonio Palumbo

  • Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

    S. Vincent Rajkumar;Jean Luc Harousseau;Brian Durie;Kenneth C. Anderson

  • A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia

    Pierre Fenaux;Claude Chastang;Sylvie Chevret;Miguel Sanz

  • Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia

    Roger G. Owen;Steven P. Treon;Ayad Al-Katib;Rafael Fonseca

  • Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

    A. Palumbo;S. V. Rajkumar;M. A. Dimopoulos;P. G. Richardson

  • Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial

    Jesús F. San-Miguel;Vânia T.M. Hungria;Sung Soo Yoon;Meral Beksac

  • Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial

    Jesús Fernando San Miguel;Jesús Fernando San Miguel;Katja Weisel;Philippe Moreau;Martha Lacy

  • Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

    S. K. Kumar;J. H. Lee;J. J. Lahuerta;G. Morgan

Frequent Co-Authors

Maria-Victoria Mateos
Maria-Victoria Mateos University of Salamanca
Joan Bladé
Joan Bladé University of Barcelona
Alberto Orfao
Alberto Orfao University of Salamanca
Ramón García-Sanz
Ramón García-Sanz University of Salamanca
Juan José Lahuerta
Juan José Lahuerta Complutense University of Madrid
Albert Oriol
Albert Oriol Autonomous University of Barcelona
Meletios A. Dimopoulos
Meletios A. Dimopoulos National and Kapodistrian University of Athens
Paul G. Richardson
Paul G. Richardson Harvard University
Pieter Sonneveld
Pieter Sonneveld Erasmus University Rotterdam
Antonio Palumbo
Antonio Palumbo University of Turin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Thinking about expanding your career options beyond a traditional medical path? There are a variety of online healthcare degrees and career pathways that may align with your interests and goals.

For those interested in mental health, consider enrolling in one of the fastest pmhnp program options, which offer a quicker route to a specialized Nurse Practitioner role. If your passion lies in leadership and management, an affordable healthcare administration degree online can open doors to administrative roles in hospitals, clinics, or health organizations.

Looking to advance further? Explore some of the cheapest mha online programs for a cost-effective way to earn your Master's in Healthcare Administration. For nurses seeking the highest clinical credentials, there are also dnp online programs cheap, allowing you to become a Doctor of Nursing Practice at an affordable price.

Each program offers unique advantages, making it easier to find a pathway that fits your schedule, budget, and long-term career vision.

Best Scientists Citing Jesús F. San Miguel

Trending Scientists

Recently Published Articles